Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.01 billion.
Market Cap
1.13T
Revenue
110.01B
Profits
-41.23B
PE Ratio
n/a
Profit Margin
-37.48%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.97B | 0.30% | 1,164,432 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.87B | -1.08% | 1,913,616 | 14.92B |
| 3 | ARGX | argenx SE | 51.30B | 1.51% | 204,426 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.47B | 0.04% | 629,512 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.35B | -0.80% | 159,054 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.53B | -1.22% | 2,881,879 | - |
| 7 | RPRX | Royalty Pharma plc | 31.08B | 0.20% | 3,075,813 | 2.44B |
| 8 | BNTX | BioNTech SE | 23.52B | 0.81% | 1,552,196 | 3.23B |
| 9 | INSM | Insmed Incorporated | 23.06B | -2.27% | 3,094,622 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 21.28B | -0.30% | 6,699,429 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.45B | 0.25% | 939,616 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.89B | 1.23% | 3,599,005 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.48B | -0.67% | 790,752 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.91B | 0.06% | 615,351 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.61B | -1.83% | 353,441 | 998.25M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.47B | 2.12% | 2,211,495 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.01B | -1.90% | 3,022,796 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.64B | 0.55% | 1,458,671 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.58B | 0.10% | 2,434,866 | 2.38B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.17B | 0.65% | 144,104 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 0.14% | 708,939 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.13B | 0.39% | 1,288,329 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.47B | 1.13% | 1,622,202 | 105.82M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.42B | 2.63% | 1,082,598 | 5.67M |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 10.12B | -0.95% | 2,344,633 | 3.24B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.96B | 1.86% | 304,539 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.04B | 1.31% | 144,305 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 8.48B | 2.32% | 631,653 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.26B | -0.38% | 14,532,401 | 140.98M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.14B | -0.10% | 2,043,182 | 1.51B |
| 31 | TECH | Bio-Techne Corporation | 7.53B | 0.25% | 2,151,166 | 1.21B |
| 32 | PCVX | Vaxcyte, Inc. | 7.37B | 1.82% | 1,413,860 | - |
| 33 | CORT | Corcept Therapeutics Incorporated | 7.15B | 10.42% | 1,890,920 | 769.10M |
| 34 | IMVT | Immunovant, Inc. | 6.86B | -1.24% | 1,754,872 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.72B | 1.15% | 330,316 | 51.48M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | 2.23% | 404,793 | 74.06M |
| 37 | CELC | Celcuity Inc. | 6.53B | -0.22% | 646,714 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.30B | -1.55% | 557,990 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.27B | 1.78% | 495,689 | 217.17M |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.03% | 1,080,162 | 15.00M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.07B | -1.69% | 864,403 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.94B | -1.59% | 668,837 | 569.61M |
| 43 | COGT | Cogent Biosciences, Inc. | 5.90B | 1.68% | 3,093,382 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.86B | 4.45% | 1,692,469 | 827.11M |
| 45 | APGE | Apogee Therapeutics, Inc. | 5.83B | -6.11% | 4,032,065 | - |
| 46 | BLTE | Belite Bio, Inc | 5.59B | 0.06% | 148,753 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.56B | -1.33% | 1,576,023 | 700.35M |
| 48 | CGON | CG Oncology, Inc. | 5.36B | -1.76% | 1,029,052 | 5.07M |
| 49 | LEGN | Legend Biotech Corporation | 5.29B | -3.49% | 1,437,437 | 1.14B |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.21B | -0.15% | 2,271,059 | 7.50M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.16B | 3.76% | 1,840,892 | 4.10M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.74B | -0.17% | 560,383 | 1.34M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.73B | 0.24% | 189,839 | 274.48M |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.44B | 7.83% | 3,113,466 | 536.20M |
| 55 | CAI | Caris Life Sciences, Inc. | 4.35B | -0.90% | 1,870,145 | 907.29M |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.27B | 1.25% | 938,780 | 22.57M |
| 57 | MANE | Veradermics, Incorporated | 4.18B | -2.31% | 471,737 | - |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | 0.03% | 861,552 | 18.07M |
| 59 | ERAS | Erasca, Inc. | 3.88B | 8.43% | 6,381,763 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | -0.03% | 3,702,884 | 596.96M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.68B | 2.79% | 1,754,485 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.63B | -0.33% | 982,249 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.61B | -0.06% | 572,802 | - |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.50B | -1.81% | 671,319 | - |
| 65 | DNLI | Denali Therapeutics Inc. | 3.21B | 4.28% | 1,625,489 | - |
| 66 | BEAM | Beam Therapeutics Inc. | 3.17B | 7.05% | 2,729,349 | 164.01M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.16B | 1.78% | 88,617 | 803.79M |
| 68 | RLAY | Relay Therapeutics, Inc. | 3.14B | 1.83% | 3,050,364 | 10.68M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.01B | -0.66% | 754,532 | 236.00M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.00B | 0.06% | 1,051,171 | - |
| 71 | TNGX | Tango Therapeutics, Inc. | 2.84B | -1.95% | 2,926,056 | 56.99M |
| 72 | KLRA | Kailera Therapeutics, Inc. | 2.84B | 1.58% | 479,489 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 2.81B | -0.10% | 573,848 | - |
| 74 | ALMS | Alumis Inc. | 2.72B | -4.48% | 822,308 | 8.40M |
| 75 | IRON | Disc Medicine, Inc. | 2.66B | 2.41% | 333,387 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 0.19% | 1,504,254 | 415.62M |
| 77 | TARS | Tarsus Pharmaceuticals, Inc. | 2.58B | -1.80% | 562,786 | 535.08M |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.57B | -0.24% | 577,201 | 225.27M |
| 79 | DFTX | Definium Therapeutics, Inc. | 2.57B | 2.80% | 1,780,900 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.52B | -2.63% | 519,002 | - |
| 81 | IMNM | Immunome, Inc. | 2.50B | 0.91% | 879,467 | 4.02M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.48B | 2.59% | 503,024 | 865.00K |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 0.07% | 1,164,254 | - |
| 84 | VERA | Vera Therapeutics, Inc. | 2.46B | -0.20% | 659,498 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | 1.08% | 1,685,021 | 670.00M |
| 86 | NKTR | Nektar Therapeutics | 2.21B | -0.24% | 1,412,095 | 55.63M |
| 87 | KOD | Kodiak Sciences Inc. | 2.19B | -2.53% | 504,266 | - |
| 88 | ZLAB | Zai Lab Limited | 2.10B | 1.30% | 716,600 | 453.28M |
| 89 | PHVS | Pharvaris N.V. | 2.05B | -1.37% | 141,852 | - |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.05B | 0.49% | 774,969 | - |
| 91 | NBTX | Nanobiotix S.A. | 2.04B | -0.74% | 26,657 | 38.27M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | 2.30% | 2,445,819 | 298.30M |
| 93 | TYRA | Tyra Biosciences, Inc. | 1.97B | -1.25% | 375,700 | - |
| 94 | SION | Sionna Therapeutics, Inc. | 1.96B | 1.28% | 189,444 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 1.96B | 1.35% | 359,109 | 32.08M |
| 96 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 6.59% | 12,819,904 | 285.61M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.91B | 1.53% | 1,157,203 | 70.92M |
| 98 | MESO | Mesoblast Limited | 1.90B | -1.61% | 193,881 | 65.38M |
| 99 | RAPP | Rapport Therapeutics, Inc. | 1.89B | -0.50% | 270,246 | 20.00M |
| 100 | AAPG | Ascentage Pharma Group International | 1.88B | 3.83% | 10,113 | 82.08M |
| 101 | NTLA | Intellia Therapeutics, Inc. | 1.88B | 6.58% | 6,548,662 | 66.09M |
| 102 | OCUL | Ocular Therapeutix, Inc. | 1.87B | 3.02% | 2,569,322 | 52.04M |
| 103 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.22% | 156,226 | 1.20B |
| 104 | ADMA | ADMA Biologics, Inc. | 1.84B | -2.82% | 3,550,279 | 509.86M |
| 105 | NVAX | Novavax, Inc. | 1.82B | 6.02% | 9,799,904 | 596.34M |
| 106 | ZYME | Zymeworks Inc. | 1.81B | -2.40% | 509,462 | 81.26M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 0.52% | 831,495 | 71.78M |
| 108 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | 2.23% | 559,531 | 899.11M |
| 109 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | 0.06% | 2,191,206 | 2.18B |
| 110 | OCS | Oculis Holding AG | 1.75B | -1.07% | 297,478 | 1.40M |
| 111 | VCEL | Vericel Corporation | 1.75B | -2.00% | 448,879 | 292.09M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -1.46% | 1,051,970 | 217.17M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.70B | 1.02% | 934,966 | 66.05M |
| 114 | BHVN | Biohaven Ltd. | 1.70B | 12.12% | 4,785,683 | - |
| 115 | CAPR | Capricor Therapeutics, Inc. | 1.69B | -0.75% | 553,687 | 11.13M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | 6.73% | 26,463,017 | 66.41M |
| 117 | ANAB | AnaptysBio, Inc. | 1.68B | -0.14% | 666,859 | 232.39M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.68B | -1.95% | 603,286 | 30.30M |
| 119 | PVLA | Palvella Therapeutics, Inc. | 1.67B | -1.13% | 113,664 | - |
| 120 | ABCL | AbCellera Biologics Inc. | 1.66B | 2.84% | 6,471,804 | 79.21M |
| 121 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 2.86% | 1,559,784 | 7.47M |
| 122 | NUVB | Nuvation Bio Inc. | 1.65B | 1.07% | 3,017,809 | 143.05M |
| 123 | INVA | Innoviva, Inc. | 1.63B | -2.43% | 597,486 | 420.69M |
| 124 | GLUE | Monte Rosa Therapeutics, Inc. | 1.62B | -0.16% | 572,559 | 42.95M |
| 125 | SLS | SELLAS Life Sciences Group, Inc. | 1.60B | 5.67% | 9,219,863 | - |
| 126 | QURE | uniQure N.V. | 1.59B | 0.08% | 516,757 | 18.09M |
| 127 | ATAI | AtaiBeckley Inc. | 1.59B | 0.70% | 4,543,361 | 3.49M |
| 128 | PGEN | Precigen, Inc. | 1.57B | 3.77% | 5,752,759 | 31.60M |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.55B | -2.63% | 222,442 | - |
| 130 | VIR | Vir Biotechnology, Inc. | 1.53B | -2.99% | 1,392,391 | 65.50M |
| 131 | GHRS | GH Research PLC | 1.53B | -3.41% | 223,205 | - |
| 132 | IMTX | Immatics N.V. | 1.53B | 1.79% | 504,475 | 43.00M |
| 133 | ARDX | Ardelyx, Inc. | 1.52B | -1.28% | 2,338,695 | 427.68M |
| 134 | MBX | MBX Biosciences, Inc. | 1.52B | 0.41% | 511,015 | - |
| 135 | INBX | Inhibrx Biosciences, Inc. | 1.51B | -3.60% | 243,766 | 1.30M |
| 136 | IMCR | Immunocore Holdings plc | 1.45B | -3.03% | 521,225 | 412.81M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.14% | 401,888 | 20.00M |
| 138 | URGN | UroGen Pharma Ltd. | 1.43B | -0.44% | 496,942 | 140.49M |
| 139 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | -0.07% | 2,466,702 | 114.48M |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.42B | -1.82% | 309,560 | - |
| 141 | SEPN | Septerna, Inc. | 1.34B | -2.81% | 178,699 | 72.26M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.34B | 0.99% | 928,670 | - |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 0.31% | 269,277 | - |
| 144 | SVRA | Savara Inc. | 1.32B | 1.36% | 834,433 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.28B | -1.68% | 433,603 | - |
| 146 | FTRE | Fortrea Holdings Inc. | 1.27B | 1.51% | 944,360 | 2.71B |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 2.73% | 148,737 | - |
| 148 | WVE | Wave Life Sciences Ltd. | 1.22B | -0.63% | 2,567,431 | 71.80M |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -3.42% | 321,619 | 10.00M |
| 150 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -0.23% | 1,571,725 | 204.73M |
| 151 | OLMA | Olema Pharmaceuticals, Inc. | 1.13B | -4.72% | 958,225 | - |
| 152 | AVLN | Avalyn Pharma Inc. | 1.12B | 0.45% | 213,198 | - |
| 153 | DBVT | DBV Technologies S.A. | 1.11B | 1.87% | 1,319,995 | 5.74M |
| 154 | IVA | Inventiva S.A. | 1.11B | 1.16% | 151,361 | 7.94M |
| 155 | EYPT | EyePoint, Inc. | 1.10B | -1.42% | 1,825,964 | 7.61M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.10B | -3.21% | 157,027 | 8.28M |
| 157 | MNKD | MannKind Corporation | 1.10B | 0.57% | 3,581,373 | 360.78M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | 0.78% | 1,244,907 | - |
| 159 | JBIO | Jade Biosciences, Inc. | 1.06B | -0.97% | 385,516 | - |
| 160 | PHAR | Pharming Group N.V. | 967.33M | -1.54% | 4,779 | 369.49M |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.70M | 5.34% | 1,931,115 | 69.64M |
| 162 | SPTX | Seaport Therapeutics, Inc. | 957.15M | 0.22% | 118,655 | - |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 953.83M | 0.39% | 1,344,996 | - |
| 164 | DRTS | Alpha Tau Medical Ltd. | 927.91M | -0.77% | 371,361 | - |
| 165 | ABUS | Arbutus Biopharma Corporation | 916.57M | - | 3,673,398 | 191.45M |
| 166 | MGTX | MeiraGTx Holdings plc | 915.91M | 3.02% | 715,945 | 79.76M |
| 167 | KURA | Kura Oncology, Inc. | 909.05M | -1.63% | 1,454,317 | 71.64M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 888.18M | 0.47% | 772,353 | - |
| 169 | ANNX | Annexon, Inc. | 883.11M | -2.36% | 1,931,018 | - |
| 170 | JANX | Janux Therapeutics, Inc. | 880.61M | 0.28% | 1,720,246 | 13.73M |
| 171 | XNCR | Xencor, Inc. | 868.94M | 0.77% | 484,450 | 97.36M |
| 172 | DRUG | Bright Minds Biosciences Inc. | 853.34M | 0.88% | 253,142 | - |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 853.08M | -3.24% | 1,088,441 | 204.89M |
| 174 | SANA | Sana Biotechnology, Inc. | 851.57M | 0.33% | 3,545,312 | - |
| 175 | AURA | Aura Biosciences, Inc. | 844.89M | 0.66% | 266,943 | - |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 844.08M | 4.04% | 794,239 | 98.99M |
| 177 | VOR | Vor Biopharma Inc. | 840.96M | 10.07% | 793,187 | - |
| 178 | EVMN | Evommune, Inc. | 840.67M | -0.04% | 346,518 | 10.00M |
| 179 | TBPH | Theravance Biopharma, Inc. | 838.25M | -0.91% | 322,259 | 109.78M |
| 180 | AVTX | Avalo Therapeutics, Inc. | 830.01M | -1.44% | 971,957 | 59.00K |
| 181 | CTMX | CytomX Therapeutics, Inc. | 829.45M | 3.25% | 4,764,339 | 35.54M |
| 182 | ODTX | Odyssey Therapeutics, Inc. | 810.92M | -2.11% | 405,167 | 2.98M |
| 183 | GERN | Geron Corporation | 808.32M | -1.56% | 8,286,827 | 196.12M |
| 184 | ABSI | Absci Corporation | 804.47M | -2.27% | 2,503,836 | 1.84M |
| 185 | OMER | Omeros Corporation | 801.20M | -4.98% | 4,359,134 | 9.89M |
| 186 | LBRX | LB Pharmaceuticals Inc | 797.21M | -1.87% | 200,382 | - |
| 187 | ALLO | Allogene Therapeutics, Inc. | 776.60M | 6.13% | 10,690,278 | 22.00K |
| 188 | RLMD | Relmada Therapeutics, Inc. | 761.49M | 1.26% | 557,976 | - |
| 189 | ANRO | Alto Neuroscience, Inc. | 716.48M | -2.94% | 153,202 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 699.47M | -0.83% | 497,606 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 693.27M | -2.63% | 842,698 | - |
| 192 | SLDB | Solid Biosciences Inc. | 691.12M | 2.03% | 868,125 | - |
| 193 | CBIO | Crescent Biopharma, Inc. | 690.83M | 2.16% | 446,976 | 11.88M |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 683.31M | 1.91% | 531,583 | - |
| 195 | SGP | SpyGlass Pharma, Inc. | 674.21M | -2.18% | 52,051 | - |
| 196 | CRMD | CorMedix Inc. | 663.70M | 2.30% | 1,088,878 | 400.05M |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 647.31M | 6.10% | 2,688,622 | 122.29M |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 639.66M | 1.55% | 683,560 | 8.37M |
| 199 | CABA | Cabaletta Bio, Inc. | 624.50M | 2.96% | 5,351,481 | - |
| 200 | IMMX | Immix Biopharma, Inc. | 609.27M | -1.24% | 1,605,831 | - |
| 201 | PRME | Prime Medicine, Inc. | 596.04M | 11.11% | 4,654,727 | 4.03M |
| 202 | VALN | Valneva SE | 592.74M | 4.79% | 72,242 | 180.25M |
| 203 | CADL | Candel Therapeutics, Inc. | 589.83M | 1.26% | 1,740,321 | - |
| 204 | ALT | Altimmune, Inc. | 579.53M | 1.71% | 2,597,333 | 36.00K |
| 205 | AGMB | AgomAb Therapeutics NV | 574.72M | 5.61% | 55,302 | - |
| 206 | TECX | Tectonic Therapeutic, Inc. | 574.19M | 1.47% | 228,357 | - |
| 207 | CLYM | Climb Bio, Inc. | 571.31M | 5.00% | 1,029,658 | - |
| 208 | ARVN | Arvinas, Inc. | 571.01M | -0.78% | 583,260 | 89.40M |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 568.98M | 0.23% | 714,171 | 151.40M |
| 210 | TRAX | First Tracks Biotherapeutics, Inc. | 563.16M | -5.39% | 336,128 | - |
| 211 | EIKN | Eikon Therapeutics, Inc. | 561.42M | 4.75% | 374,940 | - |
| 212 | EDIT | Editas Medicine, Inc. | 547.86M | 15.91% | 16,930,136 | 38.69M |
| 213 | PROK | ProKidney Corp. | 546.73M | 7.10% | 1,372,273 | 889.00K |
| 214 | RIGL | Rigel Pharmaceuticals, Inc. | 545.44M | 1.06% | 336,955 | 299.77M |
| 215 | GYRE | Gyre Therapeutics, Inc. | 540.92M | -0.34% | 80,399 | 117.05M |
| 216 | MDXG | MiMedx Group, Inc. | 537.69M | -1.63% | 756,417 | 389.42M |
| 217 | ASMB | Assembly Biosciences, Inc. | 527.48M | -4.70% | 148,992 | 71.10M |
| 218 | PRTA | Prothena Corporation plc | 525.10M | -0.30% | 616,188 | 57.94M |
| 219 | FBRX | Forte Biosciences, Inc. | 524.63M | -2.14% | 126,373 | - |
| 220 | XOMA | XOMA Royalty Corporation | 523.46M | 0.05% | 45,208 | 48.56M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 519.96M | -0.23% | 592,272 | - |
| 222 | CTNM | Contineum Therapeutics, Inc. | 502.47M | -1.90% | 148,404 | - |
| 223 | STRO | Sutro Biopharma, Inc. | 491.90M | 8.44% | 321,528 | 99.61M |
| 224 | ACHV | Achieve Life Sciences, Inc. | 490.71M | 4.82% | 1,858,804 | - |
| 225 | EPRX | Eupraxia Pharmaceuticals Inc. | 468.45M | -4.65% | 170,935 | - |
| 226 | OCGN | Ocugen, Inc. | 467.16M | 2.99% | 5,308,546 | 4.47M |
| 227 | STTK | Shattuck Labs, Inc. | 464.68M | -0.82% | 318,563 | 1.00M |
| 228 | FDMT | 4D Molecular Therapeutics, Inc. | 462.64M | 1.61% | 401,314 | 88.24M |
| 229 | FULC | Fulcrum Therapeutics, Inc. | 451.77M | 0.30% | 325,992 | 80.00M |
| 230 | UPB | Upstream Bio, Inc. | 449.51M | 0.61% | 420,408 | 3.32M |
| 231 | AUTL | Autolus Therapeutics plc | 447.12M | - | 1,531,810 | 92.62M |
| 232 | SGMT | Sagimet Biosciences Inc. | 445.85M | - | 820,350 | - |
| 233 | ANL | Adlai Nortye Ltd. | 440.00M | -3.08% | 72,170 | 5.00M |
| 234 | OVID | Ovid Therapeutics Inc. | 439.51M | 3.67% | 962,519 | 7.12M |
| 235 | ADCT | ADC Therapeutics SA | 436.27M | -2.28% | 602,782 | 79.18M |
| 236 | MNPR | Monopar Therapeutics Inc. | 432.41M | 3.08% | 174,461 | - |
| 237 | NGNE | Neurogene Inc. | 424.60M | -0.85% | 97,710 | 925.00K |
| 238 | VTVT | vTv Therapeutics Inc. | 418.45M | 1.69% | 46,095 | 36.84M |
| 239 | PRLD | Prelude Therapeutics Incorporated | 418.40M | 1.71% | 170,883 | 16.72M |
| 240 | IPSC | Century Therapeutics, Inc. | 415.72M | 6.22% | 1,468,812 | 109.16M |
| 241 | CCCC | C4 Therapeutics, Inc. | 412.08M | 7.16% | 2,632,777 | 34.86M |
| 242 | ZURA | Zura Bio Limited | 408.94M | 2.38% | 597,796 | - |
| 243 | CMPX | Compass Therapeutics, Inc. | 408.80M | 3.18% | 6,726,137 | 850.00K |
| 244 | GLSI | Greenwich LifeSciences, Inc. | 404.97M | 6.72% | 178,980 | - |
| 245 | LXEO | Lexeo Therapeutics, Inc. | 399.68M | -0.97% | 589,345 | - |
| 246 | BNTC | Benitec Biopharma Inc. | 398.51M | 1.31% | 57,567 | - |
| 247 | LYEL | Lyell Immunopharma, Inc. | 390.38M | 2.20% | 84,007 | 31.00K |
| 248 | VNDA | Vanda Pharmaceuticals Inc. | 388.48M | 3.86% | 1,181,201 | 217.78M |
| 249 | REPL | Replimune Group, Inc. | 388.09M | 2.17% | 2,217,454 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 383.54M | -2.51% | 295,434 | 69.21M |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 380.11M | 0.75% | 213,501 | 9.01M |
| 252 | IFRX | InflaRx N.V. | 377.07M | -6.57% | 680,469 | 33.82K |
| 253 | OABI | OmniAb, Inc. | 375.48M | 1.57% | 668,825 | 28.94M |
| 254 | VSTM | Verastem, Inc. | 373.46M | -2.52% | 3,412,010 | 49.59M |
| 255 | PBYI | Puma Biotechnology, Inc. | 372.08M | 0.55% | 154,305 | 227.18M |
| 256 | ARTV | Artiva Biotherapeutics, Inc. | 370.73M | -0.52% | 309,228 | 251.00K |
| 257 | LRMR | Larimar Therapeutics, Inc. | 367.43M | 1.44% | 1,709,665 | - |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 364.12M | 0.44% | 325,185 | - |
| 259 | RZLT | Rezolute, Inc. | 346.83M | 0.61% | 1,081,438 | - |
| 260 | PALI | Palisade Bio, Inc. | 346.57M | 4.02% | 2,954,067 | - |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 346.33M | 0.81% | 219,622 | 51.00M |
| 262 | RGNX | REGENXBIO Inc. | 345.86M | 6.02% | 1,534,554 | 87.82M |
| 263 | IMRX | Immuneering Corporation | 345.16M | 1.23% | 1,972,500 | - |
| 264 | NMRA | Neumora Therapeutics, Inc. | 339.80M | 1.09% | 719,894 | - |
| 265 | IVVD | Invivyd, Inc. | 332.91M | 2.73% | 2,463,478 | 55.87M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 328.69M | -3.48% | 134,022 | - |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 326.49M | -0.33% | 1,845,591 | - |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 325.32M | 5.35% | 517,346 | - |
| 269 | ABEO | Abeona Therapeutics Inc. | 324.30M | 3.64% | 1,065,369 | 14.54M |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 324.09M | 0.78% | 674,687 | 14.78M |
| 271 | SLN | Silence Therapeutics plc | 321.20M | 2.41% | 326,276 | 839.00K |
| 272 | BCYC | Bicycle Therapeutics plc | 319.04M | - | 138,842 | 63.50M |
| 273 | SRZN | Surrozen, Inc. | 307.21M | 1.11% | 38,349 | 7.49M |
| 274 | NAGE | Niagen Bioscience, Inc. | 305.68M | -0.78% | 1,118,271 | 130.42M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 301.48M | 0.26% | 963,636 | - |
| 276 | IRD | Opus Genetics, Inc. | 295.61M | 1.22% | 1,056,248 | 11.98M |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 292.46M | -2.45% | 66,784 | 5.20M |
| 278 | ACIU | AC Immune SA | 290.66M | - | 173,667 | 4.62M |
| 279 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | - | 537,459 | 1.00 |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 286.17M | 1.52% | 500,257 | 26.87M |
| 281 | MGNX | MacroGenics, Inc. | 278.39M | -2.01% | 674,946 | 157.08M |
| 282 | YDES | YD Bio Limited | 277.06M | -8.58% | 25,578 | 510.36K |
| 283 | FATE | Fate Therapeutics, Inc. | 276.25M | 10.23% | 7,441,871 | 6.32M |
| 284 | CNTX | Context Therapeutics Inc. | 273.80M | 13.31% | 1,127,930 | - |
| 285 | NVCT | Nuvectis Pharma, Inc. | 269.23M | 0.50% | 126,449 | - |
| 286 | TARA | Protara Therapeutics, Inc. | 267.53M | -0.83% | 702,782 | - |
| 287 | ADAG | Adagene Inc. | 264.29M | 7.53% | 361,379 | 7.67M |
| 288 | CLLS | Cellectis S.A. | 263.78M | -1.09% | 29,099 | 75.11M |
| 289 | ALXO | ALX Oncology Holdings Inc. | 263.74M | 1.55% | 4,239,117 | - |
| 290 | CGEN | Compugen Ltd. | 261.05M | 4.15% | 366,539 | 72.66M |
| 291 | CHRS | Coherus Oncology, Inc. | 256.05M | 1.22% | 1,199,395 | 46.88M |
| 292 | AVXL | Anavex Life Sciences Corp. | 255.77M | 1.85% | 1,157,512 | - |
| 293 | HUMA | Humacyte, Inc. | 255.32M | 3.60% | 5,846,267 | 2.02M |
| 294 | SABS | SAB Biotherapeutics, Inc. | 252.99M | -5.51% | 283,254 | 114.70K |
| 295 | FHTX | Foghorn Therapeutics Inc. | 250.71M | -2.29% | 147,793 | 28.22M |
| 296 | ALEC | Alector, Inc. | 245.37M | 0.91% | 462,444 | 18.42M |
| 297 | NERV | Minerva Neurosciences, Inc. | 245.06M | 0.77% | 90,762 | - |
| 298 | LENZ | LENZ Therapeutics, Inc. | 242.37M | -0.26% | 1,002,208 | 20.99M |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 241.25M | -0.94% | 29,103 | 18.47M |
| 300 | CDXS | Codexis, Inc. | 239.97M | 1.54% | 596,907 | 78.09M |
| 301 | TRDA | Entrada Therapeutics, Inc. | 238.90M | -1.04% | 426,494 | 5.74M |
| 302 | VYGR | Voyager Therapeutics, Inc. | 237.46M | 2.61% | 453,822 | 36.49M |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 236.53M | -0.50% | 135,669 | 32.72M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 236.27M | 0.21% | 371,222 | 7.15M |
| 305 | NKTX | Nkarta, Inc. | 228.23M | 4.25% | 600,375 | - |
| 306 | CRBU | Caribou Biosciences, Inc. | 226.98M | 6.94% | 3,737,500 | 11.20M |
| 307 | KROS | Keros Therapeutics, Inc. | 223.85M | 0.71% | 224,511 | 33.18M |
| 308 | RNA | Atrium Therapeutics, Inc. | 222.37M | -0.46% | 169,152 | 36.68M |
| 309 | HELP | Cybin Inc. | 221.66M | - | 689,335 | - |
| 310 | NGEN | NervGen Pharma Corp. | 219.84M | -2.82% | 1,522,299 | - |
| 311 | CAMP | Camp4 Therapeutics Corporation | 218.61M | 2.68% | 63,973 | 3.93M |
| 312 | QTTB | Q32 Bio Inc. | 217.89M | 81.24% | 21,152,834 | 53.74M |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 217.72M | 6.24% | 455,478 | 54.71M |
| 314 | NBP | NovaBridge Biosciences | 216.26M | 0.54% | 857,346 | - |
| 315 | RNAC | Cartesian Therapeutics, Inc. | 203.61M | 7.44% | 169,743 | 1.78M |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 202.51M | 0.11% | 624,445 | 151.12M |
| 317 | KRRO | Korro Bio, Inc. | 198.45M | 11.60% | 204,825 | 3.84M |
| 318 | ELTX | Elicio Therapeutics, Inc. | 198.13M | 7.38% | 116,883 | - |
| 319 | DTIL | Precision BioSciences, Inc. | 195.84M | 0.13% | 952,787 | 45.07M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.68M | -4.86% | 679,401 | 17.56M |
| 321 | IMUX | Immunic, Inc. | 190.70M | 7.94% | 395,608 | - |
| 322 | MIST | Milestone Pharmaceuticals Inc. | 190.47M | - | 2,236,935 | 1.78M |
| 323 | UNCY | Unicycive Therapeutics, Inc. | 188.77M | 0.14% | 1,014,992 | - |
| 324 | ENLV | Enlivex Ltd. | 188.50M | 14.33% | 1,328,024 | - |
| 325 | TLSA | Tiziana Life Sciences Ltd | 187.61M | -2.65% | 260,510 | - |
| 326 | MDWD | MediWound Ltd. | 184.17M | -14.09% | 451,104 | 14.48M |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 183.46M | 4.96% | 286,967 | - |
| 328 | CNTN | Canton Strategic Holdings, Inc. | 183.00M | -1.82% | 552,015 | - |
| 329 | GALT | Galectin Therapeutics Inc. | 177.81M | -3.23% | 430,648 | - |
| 330 | HRTX | Heron Therapeutics, Inc. | 172.21M | 3.00% | 1,646,403 | 150.71M |
| 331 | TNYA | Tenaya Therapeutics, Inc. | 171.88M | 1.29% | 3,132,089 | 225.00K |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | -0.93% | 1,119,978 | 76.38M |
| 333 | SPRO | Spero Therapeutics, Inc. | 169.65M | 2.45% | 1,774,388 | 61.19M |
| 334 | IPHA | Innate Pharma S.A. | 168.30M | 1.74% | 27,747 | 10.57M |
| 335 | ANTX | AN2 Therapeutics, Inc. | 166.66M | -2.11% | 117,697 | - |
| 336 | EQ | Equillium, Inc. | 166.29M | 13.36% | 766,347 | 4.39M |
| 337 | OKUR | OnKure Therapeutics, Inc. | 165.62M | -0.49% | 316,793 | - |
| 338 | PRQR | ProQR Therapeutics N.V. | 164.37M | -0.64% | 231,572 | 15.73M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 162.89M | -1.49% | 133,819 | 2.00M |
| 340 | MENS | Jyong Biotech Ltd. | 160.34M | -0.46% | 38,956 | - |
| 341 | TTRX | Turn Therapeutics Inc. | 157.58M | -1.31% | 13,089 | - |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 154.92M | -0.70% | 2,017,896 | 2.29M |
| 343 | HURA | TuHURA Biosciences, Inc. | 151.56M | -2.86% | 509,411 | - |
| 344 | MOLN | Molecular Partners AG | 149.87M | -0.25% | 3,744 | 856.30K |
| 345 | INDP | Indaptus Therapeutics, Inc. | 143.82M | 14.41% | 22,717 | - |
| 346 | AGEN | Agenus Inc. | 141.65M | 2.71% | 466,634 | 123.87M |
| 347 | KZIA | Kazia Therapeutics Limited | 138.95M | -2.80% | 226,047 | 1.27M |
| 348 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 138.70M | -1.14% | 2,078,204 | - |
| 349 | GUTS | Fractyl Health, Inc. | 136.31M | -6.38% | 1,052,218 | 3.00K |
| 350 | GNLX | Genelux Corporation | 135.89M | 1.66% | 216,322 | 8.00K |
| 351 | CNTB | Connect Biopharma Holdings Limited | 135.65M | - | 252,769 | 233.00K |
| 352 | SPRB | Spruce Biosciences, Inc. | 133.82M | -4.42% | 29,871 | 697.00K |
| 353 | BDTX | Black Diamond Therapeutics, Inc. | 132.37M | -0.86% | 1,899,500 | 70.00M |
| 354 | ACOG | Alpha Cognition Inc. | 124.77M | -2.55% | 32,211 | 10.83M |
| 355 | CRDF | Cardiff Oncology, Inc. | 123.75M | -6.70% | 1,056,508 | 525.00K |
| 356 | ALPS | Alps Group Inc | 123.15M | 1.58% | 2,222 | 3.74M |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 122.40M | -5.93% | 74,016 | 39.99K |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 120.48M | 0.58% | 82,205 | - |
| 359 | PLYX | Polaryx Therapeutics, Inc. | 118.83M | -2.71% | 743,059 | - |
| 360 | ENGN | enGene Therapeutics Inc. | 115.22M | -2.27% | 1,242,358 | - |
| 361 | CBUS | Cibus, Inc. | 114.42M | 4.90% | 327,368 | 4.29M |
| 362 | COYA | Coya Therapeutics, Inc. | 111.89M | 1.27% | 57,731 | 7.94M |
| 363 | VANI | Vivani Medical, Inc. | 110.38M | 3.23% | 197,149 | - |
| 364 | PYXS | Pyxis Oncology, Inc. | 109.60M | 6.13% | 430,104 | 13.86M |
| 365 | SEER | Seer, Inc. | 106.64M | 1.07% | 135,095 | 15.17M |
| 366 | CGTX | Cognition Therapeutics, Inc. | 106.33M | -4.03% | 798,928 | - |
| 367 | PEPG | PepGen Inc. | 105.14M | -0.65% | 669,137 | - |
| 368 | ONCY | Oncolytics Biotech Inc. | 104.52M | 11.07% | 1,656,474 | - |
| 369 | VRCA | Verrica Pharmaceuticals Inc. | 104.10M | 0.66% | 25,889 | 37.16M |
| 370 | ALDX | Aldeyra Therapeutics, Inc. | 103.15M | -3.93% | 896,730 | - |
| 371 | INO | Inovio Pharmaceuticals, Inc. | 102.42M | -0.79% | 1,422,114 | 65.34K |
| 372 | RNTX | Rein Therapeutics Inc. | 98.62M | -0.93% | 148,728 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 98.33M | -3.55% | 759,748 | - |
| 374 | ICCC | ImmuCell Corporation | 96.17M | 1.24% | 21,419 | 29.93M |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 94.82M | 1.01% | 805,819 | 3.17M |
| 376 | PMN | ProMIS Neurosciences, Inc. | 93.94M | 1.11% | 11,862 | - |
| 377 | PTHS | Pelthos Therapeutics Inc. | 93.70M | -0.77% | 10,990 | 27.70M |
| 378 | LONA | LeonaBio, Inc. | 92.15M | 1.45% | 51,230 | - |
| 379 | FBIO | Fortress Biotech, Inc. | 91.68M | 2.60% | 255,382 | 66.16M |
| 380 | PYPD | PolyPid Ltd. | 91.03M | -1.45% | 238,737 | - |
| 381 | ATRA | Atara Biotherapeutics, Inc. | 89.72M | 9.68% | 168,937 | 23.14M |
| 382 | ACET | Adicet Bio, Inc. | 89.26M | 2.04% | 100,692 | - |
| 383 | ANIX | Anixa Biosciences, Inc. | 88.85M | -2.93% | 68,658 | - |
| 384 | OKYO | OKYO Pharma Limited | 88.69M | -1.17% | 28,673 | - |
| 385 | AARD | Aardvark Therapeutics, Inc. | 87.05M | -5.00% | 209,964 | - |
| 386 | NRXS | NeurAxis, Inc. | 85.72M | 6.43% | 146,232 | 4.28M |
| 387 | ANVS | Annovis Bio, Inc. | 85.51M | -2.43% | 1,180,815 | - |
| 388 | HYFT | MindWalk Holdings Corp. | 84.93M | 4.91% | 355,915 | 20.70M |
| 389 | OSTX | OS Therapies Incorporated | 84.18M | 8.00% | 728,648 | - |
| 390 | EXOZ | eXoZymes, Inc. | 84.03M | - | 1,128 | -700.00 |
| 391 | CSBR | Champions Oncology, Inc. | 81.52M | -2.00% | 4,607 | 57.95M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 79.65M | -1.50% | 320,353 | - |
| 393 | RLYB | Rallybio Corporation | 76.86M | -1.16% | 18,224 | 858.00K |
| 394 | PLRX | Pliant Therapeutics, Inc. | 76.78M | - | 216,690 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 75.50M | -2.75% | 697,781 | - |
| 396 | LIXT | Lixte Biotechnology Holdings, Inc. | 74.59M | 13.63% | 236,622 | - |
| 397 | XBIT | XBiotech Inc. | 74.39M | 1.67% | 16,299 | - |
| 398 | MCRB | Seres Therapeutics, Inc. | 73.89M | 0.53% | 25,647 | 1.15M |
| 399 | FLNA | Filana Therapeutics, Inc. | 72.46M | 6.38% | 626,069 | - |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 71.05M | -0.60% | 415,902 | - |
| 401 | EDSA | Edesa Biotech, Inc. | 70.82M | -17.84% | 629,912 | - |
| 402 | OTLK | Outlook Therapeutics, Inc. | 70.77M | 46.30% | 84,215,620 | 333.14K |
| 403 | BYSI | BeyondSpring Inc. | 70.31M | 11.04% | 101,228 | 1.88M |
| 404 | TCRX | TScan Therapeutics, Inc. | 69.93M | - | 507,257 | 9.14M |
| 405 | ATHE | Alterity Therapeutics Limited | 69.84M | -0.74% | 14,394 | 4.43M |
| 406 | IBIO | iBio, Inc. | 67.95M | 3.30% | 593,118 | 300.00K |
| 407 | IMA | ImageneBio, Inc. | 66.89M | 1.89% | 21,584 | 800.00K |
| 408 | CUE | Cue Biopharma, Inc. | 66.52M | 2.02% | 32,691 | 32.73M |
| 409 | MNOV | MediciNova, Inc. | 65.46M | -2.92% | 95,625 | 596.64K |
| 410 | PMVP | PMV Pharmaceuticals, Inc. | 64.00M | -2.44% | 368,257 | - |
| 411 | PDSB | PDS Biotechnology Corporation | 61.96M | 0.91% | 921,281 | - |
| 412 | ENTX | Entera Bio Ltd. | 58.58M | -1.65% | 189,784 | 42.00K |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 57.12M | -3.93% | 64,234 | - |
| 414 | IMMP | Immutep Limited | 55.74M | -4.21% | 2,157,698 | 5.28M |
| 415 | TIL | Instil Bio, Inc. | 55.21M | 0.25% | 12,215 | - |
| 416 | RADX | Radiopharm Theranostics Limited | 53.11M | -1.52% | 16,565 | 10.86M |
| 417 | IBO | Impact BioMedical Inc. | 52.90M | -4.18% | 80,001 | 39.00K |
| 418 | CING | Cingulate Inc. | 52.57M | -17.15% | 1,412,962 | - |
| 419 | MREO | Mereo BioPharma Group plc | 52.47M | -1.50% | 57,856,516 | 500.00K |
| 420 | HYPD | Hyperion DeFi, Inc. | 51.14M | -2.70% | 499,796 | 1.04M |
| 421 | GOSS | Gossamer Bio, Inc. | 51.14M | -0.95% | 16,247,267 | 55.54M |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 50.82M | -0.74% | 262,953 | 22.33M |
| 423 | INKT | MiNK Therapeutics, Inc. | 50.72M | -2.49% | 13,460 | - |
| 424 | ACTU | Actuate Therapeutics, Inc. | 50.48M | -4.09% | 153,952 | - |
| 425 | XLO | Xilio Therapeutics, Inc. | 49.90M | -0.12% | 23,207 | 53.48M |
| 426 | ESLA | Estrella Immunopharma, Inc. | 49.49M | - | 21,775 | - |
| 427 | QNTM | Quantum BioPharma Ltd. | 48.80M | 8.37% | 551,568 | - |
| 428 | ATYR | aTyr Pharma, Inc. | 46.89M | -1.26% | 2,516,947 | 190.00K |
| 429 | PSTV | Plus Therapeutics, Inc. | 45.56M | 0.61% | 108,267 | 5.18M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | - | 41,731 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 44.09M | 3.43% | 40,168 | - |
| 432 | KALA | KALA BIO, Inc. | 43.31M | 7.37% | 46,091 | - |
| 433 | RNXT | RenovoRx, Inc. | 41.96M | 1.69% | 226,770 | 1.49M |
| 434 | NTRB | Nutriband Inc. | 41.39M | -2.30% | 5,737 | 2.04M |
| 435 | NNVC | NanoViricides, Inc. | 39.87M | 15.89% | 28,930,013 | - |
| 436 | VERU | Veru Inc. | 37.40M | 0.87% | 133,031 | 16.89M |
| 437 | INMB | INmune Bio Inc. | 37.22M | -2.10% | 218,645 | 50.00K |
| 438 | LTRN | Lantern Pharma Inc. | 37.10M | -2.07% | 148,385 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | 1.72% | 103,473 | 90.00K |
| 440 | GRCE | Grace Therapeutics, Inc. | 36.05M | -1.27% | 89,118 | - |
| 441 | ABVC | ABVC BioPharma, Inc. | 35.13M | 7.75% | 232,037 | 797.92K |
| 442 | DARE | Daré Bioscience, Inc. | 34.90M | -0.43% | 255,948 | 1.16M |
| 443 | ALGS | Aligos Therapeutics, Inc. | 34.65M | -2.44% | 93,509 | 4.71M |
| 444 | LITS | Lite Strategy, Inc. | 34.03M | -4.76% | 471,241 | - |
| 445 | EVAX | Evaxion A/S | 33.82M | -1.34% | 86,212 | 7.53M |
| 446 | BOLD | Boundless Bio, Inc. | 32.95M | - | 81,924 | - |
| 447 | NRSN | NeuroSense Therapeutics Ltd. | 31.65M | 2.68% | 164,530 | - |
| 448 | SNTI | Senti Biosciences Holdings, Inc. | 31.46M | 1.79% | 231,071 | 38.00K |
| 449 | TVRD | Tvardi Therapeutics, Inc. | 30.96M | -4.07% | 77,110 | - |
| 450 | PLRZ | Polyrizon Ltd. | 30.87M | 2.61% | 41,797 | - |
| 451 | APLM | Apollomics, Inc. | 30.61M | -1.06% | 24,208 | 8.84M |
| 452 | TVGN | Tevogen Bio Holdings Inc. | 30.11M | -16.40% | 147,243 | - |
| 453 | LSTA | Lisata Therapeutics, Inc. | 29.81M | 3.12% | 79,482 | 170.00K |
| 454 | GRDX | GridAI Technologies Corp. | 29.39M | 2.82% | 39,794 | - |
| 455 | NEUP | Neuphoria Therapeutics Inc. | 29.18M | -1.10% | 15,637 | -13.27K |
| 456 | SKYE | Skye Bioscience, Inc. | 29.10M | 0.78% | 98,273 | - |
| 457 | IGC | IGC Pharma, Inc. | 28.65M | 1.68% | 447,347 | 1.11M |
| 458 | BRNS | Barinthus Biotherapeutics plc | 28.59M | 2.67% | 4,362 | 14.97M |
| 459 | KYNB | Kyntra Bio, Inc. | 28.38M | 2.34% | 9,298 | 7.44M |
| 460 | CRVO | CervoMed Inc. | 28.15M | -0.33% | 68,917 | 2.09M |
| 461 | DYAI | Dyadic International, Inc. | 27.69M | 0.65% | 26,748 | 3.81M |
| 462 | SER | Serina Therapeutics, Inc. | 26.82M | -6.25% | 44,176 | 130.00K |
| 463 | ALLR | Allarity Therapeutics, Inc. | 26.75M | 2.67% | 505,578 | 345.00K |
| 464 | CELU | Celularity Inc. | 26.49M | 2.03% | 201,545 | 26.55M |
| 465 | BCTX | BriaCell Therapeutics Corp. | 26.47M | 6.14% | 216,088 | - |
| 466 | HOTH | Hoth Therapeutics, Inc. | 26.01M | 92.01% | 165,804,715 | - |
| 467 | TPST | Tempest Therapeutics, Inc. | 25.68M | 1.13% | 48,138 | - |
| 468 | PLUR | Pluri Inc. | 25.46M | 2.16% | 15,073 | 1.08M |
| 469 | PTN | Palatin Technologies, Inc. | 25.42M | 1.59% | 7,076 | 12.88M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 25.26M | -1.12% | 232,503 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 25.09M | 1.29% | 145,391 | - |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 24.73M | -1.98% | 327,262 | 789.00K |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.18M | - | 40,195 | 3.55M |
| 474 | HOWL | Werewolf Therapeutics, Inc. | 23.81M | 5.81% | 396,568 | 1.14M |
| 475 | LGVN | Longeveron Inc. | 23.28M | -1.99% | 341,346 | 1.22M |
| 476 | TRAW | Traws Pharma, Inc. | 23.18M | -3.16% | 1,313,473 | 2.73M |
| 477 | KTTA | Pasithea Therapeutics Corp. | 23.15M | 1.88% | 144,254 | - |
| 478 | VYNE | VYNE Therapeutics Inc. | 22.66M | 0.06% | 123,578 | 454.00K |
| 479 | SNSE | Sensei Biotherapeutics, Inc. | 22.34M | 1.09% | 53,510 | - |
| 480 | NXTC | NextCure, Inc. | 21.90M | -13.53% | 96,994 | - |
| 481 | CRIS | Curis, Inc. | 21.11M | 6.84% | 196,300 | 7.06M |
| 482 | CVM | CEL-SCI Corporation | 20.43M | -1.40% | 252,457 | - |
| 483 | AEON | AEON Biopharma, Inc. | 19.73M | -2.60% | 16,406 | - |
| 484 | GNTA | Genenta Science S.p.A. | 19.36M | 37.35% | 8,052,547 | - |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 18.94M | -1.00% | 514,271 | 5.61M |
| 486 | QNCX | Quince Therapeutics, Inc. | 18.75M | -4.17% | 985,644 | - |
| 487 | NCEL | NewcelX Ltd. | 18.57M | 9.52% | 924,513 | - |
| 488 | LPCN | Lipocine Inc. | 18.30M | 0.88% | 86,278 | 2.00M |
| 489 | AKTX | Akari Therapeutics, Plc | 18.23M | -10.58% | 492,170 | - |
| 490 | XCUR | Exicure, Inc. | 17.78M | 4.34% | 16,410 | 500.00K |
| 491 | INAB | IN8bio, Inc. | 17.72M | 6.51% | 84,194 | - |
| 492 | PASG | Passage Bio, Inc. | 17.71M | -0.54% | 39,430 | - |
| 493 | MTVA | MetaVia Inc. | 17.25M | 12.46% | 5,555,241 | - |
| 494 | OSRH | OSR Holdings, Inc. | 16.99M | -2.22% | 2,712,683 | 2.63M |
| 495 | PHGE | BiomX Inc. | 15.73M | -4.32% | 5,097,769 | - |
| 496 | HIND | Vyome Holdings, Inc. | 15.72M | -3.03% | 17,199 | 152.72K |
| 497 | COCP | Cocrystal Pharma, Inc. | 15.44M | -0.88% | 122,860 | 225.00K |
| 498 | LEXX | Lexaria Bioscience Corp. | 15.18M | -7.98% | 83,902 | 368.00K |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 15.14M | -5.20% | 60,677 | - |
| 500 | MLEC | Moolec Science SA | 15.08M | -2.42% | 6,864 | 7.83M |